MS
Morgan Stanley
MS has the edge over RKT overall, supported by lower modeled downside and stronger modeled upside.
RKT
Rocket Companies, Inc.
RKT offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
RKT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
RKT's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like RKT.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS has the edge over RKT in the historical PE scenario, which offers more potential upside but is not a forecast.
RKT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 0.7x | $0.36 | -97% |
| Fair | 0.9x | $0.47 | -97% |
| Forward | 23x | $13.71 | — |
| Current | 26x | $13.71 | — |
| Expensive | 57x | $30.08 | +119% |
Historical ranges are pointers, not guarantees.
RKT's PE is 26x, but its earnings don't support one, so it isn't a reliable read right now.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over RKT on the outlook, with more favorable revenue expectations.
RKT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKT's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS's earnings per share have climbed steadily: $12.60 over the past year, up 29% from the year before, and higher year over year for 10 quarters in a row.
RKT Earnings Per Share
RKT and MS do not have enough comparable growth data to identify a winner.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over RKT on profitability, with a higher operating margin.
RKT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.3B | +105% |
| Q2 2026 | $2.8B | +105% |
| Q1 2026 | $2.9B | +184% |
| Q4 2025 | $2.7B | +52% |
| Q3 2025 | $1.6B | +148% |
| Q2 2025 | $1.4B | +4.6% |
| Q1 2025 | $1B | -25% |
| Q4 2024 | $1.8B | +155% |
RKT's revenue is recovering but still below its 2020 peak: $3.3B last quarter, up 105% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 29% | +41 points |
| Q2 2026 | 10% | +8.3 points |
| Q1 2026 | 14% | +35 points |
| Q4 2025 | 6.3% | -32 points |
| Q3 2025 | -11% | +65 points |
| Q2 2025 | 1.8% | -13 points |
| Q1 2025 | -22% | -43 points |
| Q4 2024 | 38% | +73 points |
RKT's operating margin was 29% last quarter, up 41 points from the same quarter a year ago.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
RKT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.9B | +$1.9B |
| Q2 2026 | -$1.2B | +$619.6M |
| Q1 2026 | $1.8B | +$2.6B |
| Q4 2025 | -$1.3B | -170% |
| Q3 2025 | -$71.8M | +$1.3B |
| Q2 2025 | -$1.9B | -$1.7B |
| Q1 2025 | -$811M | +$2.2B |
| Q4 2024 | $1.8B | +31% |
RKT has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over RKT on shareholder dilution, with a more favorable share count trend.
RKT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +1.9M shares |
| 1 year | +42% | +842M shares |
| 3 years | +43% | +856M shares |
RKT has 2.8B diluted shares, up 42% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | $11.7M |
| Q3 2022 | $20.6M |
| Q2 2022 | $45.3M |
| Q1 2022 | $100.2M |
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
RKT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.3x | Elevated |
| Q2 2026 | 6.4x | High |
| Q1 2026 | 9.5x | High |
| Q4 2025 | 287.9x | High |
| Q3 2025 | 29.1x | High |
| Q2 2025 | 136.0x | High |
| Q1 2025 | 39.5x | High |
| Q4 2024 | 12.1x | High |
RKT has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
RKT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.4 | Neutral |
| Stochastic | 72.6 | Neutral |
RKT's weekly RSI is 50 (neutral) and its Stochastic is 73 (neutral).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over RKT on valuation relative to its sector.
RKT PE vs Financial Services Sector
| Metric | RKT | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 13x | 99% above |
| PE % | 62 | 62 | Same percentile |
RKT is trading at 26x earnings, a 99% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
RKT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.4 | 10% above |
| 20 week MA | $13.3 | 3.2% above |
| 50 week MA | $15.3 | 11% below |
| 100 week MA | $15.1 | 9.3% below |
| 200 week MA | $13.6 | 0.9% above |
RKT's trend is mixed: it's above three of its five weekly moving averages, and 0.9% above its 200-week average.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over RKT on returns for 2026, with the stronger performance.
RKT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.9 | $20.8 | -16% |
| 2021 | $20.8 | $15.3 | -27% |
| 2022 | $15.3 | $7.29 | -52% |
| 2023 | $7.29 | $14.5 | +99% |
| 2024 | $14.5 | $11.1 | -23% |
| 2025 | $11.1 | $19.4 | +75% |
| 2026 YTD | $19.4 | $13.7 | -29% |
RKT has finished lower in four of the last six years. It's down 29% so far in 2026.